Miceline Mesidor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miceline Mesidor has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Marie-Elise Parent
Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Canada
29 shared publications - Charlotte Salmon
Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France
28 shared publications - Hugues Richard
Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, Université du Québec, Laval, QC, Canada
28 shared publications - Marie-Claude Rousseau
Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique (INRS), Laval, Canada
28 shared publications - Andrea R. Spence
Center for Clinical Epidemiology and Community Studies Jewish General Hospital Montreal Quebec Canada
27 shared publications - Deborah Weiss
Department of National Defense, Government of Canada, Ottawa, Ontario, Canada
27 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Oxford University Press (OUP) in AJE Advances: Research in Epidemiology
- Vol. 2 (3)
Estimation of attributable fractions for time-to-event outcomes using an inverse probability weighted Kaplan–Meier estimator
Population attributable fractions aim to quantify the proportion of the cases of an outcome (eg, a disease) that would have been avoided had no individuals in the population been exposed to a given exposure. This quantity thus plays a crucial role in epidemiology and public health, notably to guide policies, interventions, or to assess the burden of a disease due to a particular exposure. Various statistical methods have been proposed to estimate attributable fractions using observational data. When time-to-event data are used, several of these formulas yield invalid results. Alternative valid formulas are available but remain scarcely used. We propose a new estimator of the attributable fraction that is both conceptually simple and easy to implement using common statistical software. Our proposed estimator makes use of the Kaplan–Meier estimator to address censoring and potentially non-proportional hazards, as well as inverse probability weighting to control confounding. Non-parametric bootstrap is proposed to produce inferences. A simulation study is used to illustrate and compare our proposed estimator to several alternatives. The results showcase the bias of many commonly used traditional approaches and the validity of our estimator under its working assumptions.
- 1 April 2026
- Published by Oxford University Press (OUP) in AJE Advances: Research in Epidemiology
- Vol. 2 (3)
Open AccessEstimation of attributable fractions for time-to-event outcomes using an inverse probability weighted Kaplan–Meier estimator
Population attributable fractions aim to quantify the proportion of the cases of an outcome (eg, a disease) that would have been avoided had no individuals in the population been exposed to a given exposure. This quantity thus plays a crucial role in epidemiology and public health, notably to guide policies, interventions, or to assess the burden of a disease due to a particular exposure. Various statistical methods have been proposed to estimate attributable fractions using observational data. When time-to-event data are used, several of these formulas yield invalid results. Alternative valid formulas are available but remain scarcely used. We propose a new estimator of the attributable fraction that is both conceptually simple and easy to implement using common statistical software. Our proposed estimator makes use of the Kaplan–Meier estimator to address censoring and potentially non-proportional hazards, as well as inverse probability weighting to control confounding. Non-parametric bootstrap is proposed to produce inferences. A simulation study is used to illustrate and compare our proposed estimator to several alternatives. The results showcase the bias of many commonly used traditional approaches and the validity of our estimator under its working assumptions.
- Open Access
- 1 March 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 110, 107103
Medication trajectories among persons with multiple sclerosis in a Quebec birth cohort
- 1 March 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 110, 107103
Open AccessMedication trajectories among persons with multiple sclerosis in a Quebec birth cohort
- Open Access
- 21 August 2025
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (5) , 1438-1446
Use of causal inference methods in case–control studies: a methodology review
The use of causal inference methods in cohort studies has increased considerably in recent years. However, their use has been limited in case–control studies. This report aimed at providing a detailed review of causal inference methods used in case–control studies and to review and examine their applications in previous studies. Several methods have been used to facilitate causal inference in case–control studies, including intercept-adjustment, propensity scores, and weight-based and doubly robust estimators. We used the Medical Literature Analysis and Retrieval System Online database to identify original peer-reviewed case–control studies conducted from March 2014 to March 2024 that applied these methods. We identified 418 studies, 23 of which met the inclusion criteria. Most studies involved case–control matching (individual or frequency) and included incident cases. The covariate-conditional odds ratio was the most frequently reported estimated parameter. Sixty-five percent of included studies considered an adjustment for sampling bias, most often using inverse-probability of observation weighting and case–control targeted maximum likelihood approaches. We are still in the early stages of development and application of causal inference methods for case–control studies. Their implementation and new techniques to address time-varying confounding can improve the validity of study findings and should be encouraged.
- 21 August 2025
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (5) , 1438-1446
Open AccessUse of causal inference methods in case–control studies: a methodology review
The use of causal inference methods in cohort studies has increased considerably in recent years. However, their use has been limited in case–control studies. This report aimed at providing a detailed review of causal inference methods used in case–control studies and to review and examine their applications in previous studies. Several methods have been used to facilitate causal inference in case–control studies, including intercept-adjustment, propensity scores, and weight-based and doubly robust estimators. We used the Medical Literature Analysis and Retrieval System Online database to identify original peer-reviewed case–control studies conducted from March 2014 to March 2024 that applied these methods. We identified 418 studies, 23 of which met the inclusion criteria. Most studies involved case–control matching (individual or frequency) and included incident cases. The covariate-conditional odds ratio was the most frequently reported estimated parameter. Sixty-five percent of included studies considered an adjustment for sampling bias, most often using inverse-probability of observation weighting and case–control targeted maximum likelihood approaches. We are still in the early stages of development and application of causal inference methods for case–control studies. Their implementation and new techniques to address time-varying confounding can improve the validity of study findings and should be encouraged.
- 13 February 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 180, 111723
Author’s reply: “The importance of properly specifying your target trial emulation: commentary on Mésidor et al.”
- 13 February 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 180, 111723
Author’s reply: “The importance of properly specifying your target trial emulation: commentary on Mésidor et al.”
- 6 March 2024
- Published by Elsevier in Bulletin du Cancer
- Vol. 111 (4) , 356-362
Analyse des effets des inhibiteurs de l’aromatase en traitement prolongé chez les femmes ménopausées atteintes d’un cancer du sein non métastatique hormonodépendant ayant déjà reçu cinq ans d’hormonothérapie adjuvante : revue systématique et méta-analyse
- 6 March 2024
- Published by Elsevier in Bulletin du Cancer
- Vol. 111 (4) , 356-362
Analyse des effets des inhibiteurs de l’aromatase en traitement prolongé chez les femmes ménopausées atteintes d’un cancer du sein non métastatique hormonodépendant ayant déjà reçu cinq ans d’hormonothérapie adjuvante : revue systématique et méta-analyse
- Open Access
- 15 February 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 168, 111284
Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation
- 15 February 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 168, 111284
Open AccessEffect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation
- 14 February 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (2)
Cohort Profile Update: The Québec Birth Cohort on Immunity and Health (CO·MMUNITY)
The overarching aim of the Quebec Birth Cohort on Immunity and Health, established in 2010, was to assess the occurrence of autoimmune and inflammatory diseases in relation to a non-specific stimulation of the immune function in early age, resulting from Bacillus Calmette-Guerin (BCG) vaccination. 1 It was originally set up to estimate the association of BCG vaccination with childhood diabetes and asthma. All individuals born in the province of Quebec, Canada, in 1974 after at least 32 weeks of gestation were eligible. Probabilistic linkage allowed the merging of data from the Birth Registry and the Healthcare Registration File, constituting the cohort base. 1 Data were obtained from the Quebec BCG vaccination registry and administrative health databases. In total, 81 496 individuals were successfully linked and included in the cohort (90.5% of those who were eligible). Data were extracted until 1994 and included sociodemographic characteristics, vital status and use of health services for asthma, allergic diseases and diabetes. Validated algorithms were applied to identify disease incidence based on administrative health data. Additional data on potential confounders of the association between BCG vaccination and asthma were collected using a two-stage sampling approach with a balanced design (Survey on Childhood Environment and Allergic Diseases, 2012). 2 Equal numbers of participants were randomly sampled among four groups defined by BCG vaccination (yes/no) and asthma status (yes/no). Information collected from the 1643 participants included sociodemographic, perinatal, environmental and health- and immunization-related factors unavailable in administrative databases. 1–3
- 14 February 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (2)
Cohort Profile Update: The Québec Birth Cohort on Immunity and Health (CO·MMUNITY)
The overarching aim of the Quebec Birth Cohort on Immunity and Health, established in 2010, was to assess the occurrence of autoimmune and inflammatory diseases in relation to a non-specific stimulation of the immune function in early age, resulting from Bacillus Calmette-Guerin (BCG) vaccination. 1 It was originally set up to estimate the association of BCG vaccination with childhood diabetes and asthma. All individuals born in the province of Quebec, Canada, in 1974 after at least 32 weeks of gestation were eligible. Probabilistic linkage allowed the merging of data from the Birth Registry and the Healthcare Registration File, constituting the cohort base. 1 Data were obtained from the Quebec BCG vaccination registry and administrative health databases. In total, 81 496 individuals were successfully linked and included in the cohort (90.5% of those who were eligible). Data were extracted until 1994 and included sociodemographic characteristics, vital status and use of health services for asthma, allergic diseases and diabetes. Validated algorithms were applied to identify disease incidence based on administrative health data. Additional data on potential confounders of the association between BCG vaccination and asthma were collected using a two-stage sampling approach with a balanced design (Survey on Childhood Environment and Allergic Diseases, 2012). 2 Equal numbers of participants were randomly sampled among four groups defined by BCG vaccination (yes/no) and asthma status (yes/no). Information collected from the 1643 participants included sociodemographic, perinatal, environmental and health- and immunization-related factors unavailable in administrative databases. 1–3
- Open Access
- 8 February 2024
- Published by Wiley in Pharmaceutical Statistics
- Vol. 23 (4) , 511-529
Assessing the performance of group‐based trajectory modeling method to discover different patterns of medication adherence
It is well known that medication adherence is critical to patient outcomes and can decrease patient mortality. The Pharmacy Quality Alliance (PQA) has recognized and identified medication adherence as an important indicator of medication‐use quality. Hence, there is a need to use the right methods to assess medication adherence. The PQA has endorsed the proportion of days covered (PDC) as the primary method of measuring adherence. Although easy to calculate, the PDC has however several drawbacks as a method of measuring adherence. PDC is a deterministic approach that cannot capture the complexity of a dynamic phenomenon. Group‐based trajectory modeling (GBTM) is increasingly proposed as an alternative to capture heterogeneity in medication adherence. The main goal of this paper is to demonstrate, through a simulation study, the ability of GBTM to capture treatment adherence when compared to its deterministic PDC analogue and to the nonparametric longitudinal K‐means. A time‐varying treatment was generated as a quadratic function of time, baseline, and time‐varying covariates. Three trajectory models are considered combining a cat's cradle effect, and a rainbow effect. The performance of GBTM was compared to the PDC and longitudinal K‐means using the absolute bias, the variance, the c‐statistics, the relative bias, and the relative variance. For all explored scenarios, we find that GBTM performed better in capturing different patterns of medication adherence with lower relative bias and variance even under model misspecification than PDC and longitudinal K‐means.
- 8 February 2024
- Published by Wiley in Pharmaceutical Statistics
- Vol. 23 (4) , 511-529
Open AccessAssessing the performance of group‐based trajectory modeling method to discover different patterns of medication adherence
It is well known that medication adherence is critical to patient outcomes and can decrease patient mortality. The Pharmacy Quality Alliance (PQA) has recognized and identified medication adherence as an important indicator of medication‐use quality. Hence, there is a need to use the right methods to assess medication adherence. The PQA has endorsed the proportion of days covered (PDC) as the primary method of measuring adherence. Although easy to calculate, the PDC has however several drawbacks as a method of measuring adherence. PDC is a deterministic approach that cannot capture the complexity of a dynamic phenomenon. Group‐based trajectory modeling (GBTM) is increasingly proposed as an alternative to capture heterogeneity in medication adherence. The main goal of this paper is to demonstrate, through a simulation study, the ability of GBTM to capture treatment adherence when compared to its deterministic PDC analogue and to the nonparametric longitudinal K‐means. A time‐varying treatment was generated as a quadratic function of time, baseline, and time‐varying covariates. Three trajectory models are considered combining a cat's cradle effect, and a rainbow effect. The performance of GBTM was compared to the PDC and longitudinal K‐means using the absolute bias, the variance, the c‐statistics, the relative bias, and the relative variance. For all explored scenarios, we find that GBTM performed better in capturing different patterns of medication adherence with lower relative bias and variance even under model misspecification than PDC and longitudinal K‐means.
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Figure 2. Directed acyclic graph of the association between chest hair amount and prostate cancer. In green, variables of interest. In orange, potential confounding factors (due to the paucity of reports on risk factors in the literature, we elected to take a conservative approach and limited adjustments to age and ancestry).
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Figure 2. Directed acyclic graph of the association between chest hair amount and prostate cancer. In green, variables of interest. In orange, potential confounding factors (due to the paucity of reports on risk factors in the literature, we elected to take a conservative approach and limited adjustments to age and ancestry).
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 7. Association between joint exposure of baldness and chest hair amount, and odds of prostate cancer, according to cancer aggressiveness (Gleason score <8, Gleason score ≥ 8), Prostate Cancer & Environment Study, Montreal, Canada, 2005–2012
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 7. Association between joint exposure of baldness and chest hair amount, and odds of prostate cancer, according to cancer aggressiveness (Gleason score <8, Gleason score ≥ 8), Prostate Cancer & Environment Study, Montreal, Canada, 2005–2012